|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|
| OPERATING ACTIVITIES | |
| Net income | |
| Adjustments to reconcile net income to net cash provided by operating activities: | |
| Depreciation | |
| Amortization of intangible assets | |
| Non-cash lease expense | |
| Deferred income taxes | |
| Stock-based compensation | |
| Amortization of deferred debt issuance costs | |
| Loss on sale and dispositions of patient equipment and other | |
| Loss from unconsolidated joint venture | |
| Gain from derecognition of nonfinancial asset | |
| Changes in operating assets and liabilities, net of effects from acquisitions: | |
| Accounts receivable | |
| Inventories | |
| Prepaid expenses and other assets | |
| Accounts payable | |
| Accrued payroll and related taxes and benefits | |
| Operating lease liabilities | |
| Income taxes payable | |
| Deferred revenue | |
| Legal reserve | |
| Accrued expenses | |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | |
| INVESTING ACTIVITIES | |
| Purchases of patient equipment and property, equipment and improvements | |
| Proceeds from sale of patient equipment and other | |
| Preferred distribution from equity method investment | |
| Issuance of note receivable, related party | |
| Cash paid for acquisitions, net of cash received | |
| NET CASH USED IN INVESTING ACTIVITIES | |
| FINANCING ACTIVITIES | |
| Payments on asset financing | |
| Payments on debt | |
| Distribution payments | |
| Payments for tax withholdings from equity-based compensation activity | |
| NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES | |
| NET INCREASE IN CASH AND CASH EQUIVALENTS | |
| CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | |
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | |
| NONCASH INVESTING AND FINANCING TRANSACTIONS | |
| Unpaid purchases | |
| Unpaid purchases, extended payment terms | |
| Non-cash contribution of software and other intellectual property |
Loading...
